Currently holds positions in Amicus Therapeutics Inc and Ardelyx Inc
Position | Company | Period |
---|---|---|
Lead Independent Director | Amicus Therapeutics Inc | Sept. 7, 2018 - |
President, Chief Executive Officer, Director | Ardelyx Inc | March 1, 2009 - |
Independent Director | Amicus Therapeutics Inc | Jan. 1, 2004 - Sept. 7, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-05-01 | 2024-04-29 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
30,000
-2.2%
6.40192,057 USD |
30,000 -2.2% | 6.40 | 192,057 USD | |
2024-04-17 | 2024-04-15 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
7,500
-0.6%
7.0652,924 USD |
7,500 -0.6% | 7.06 | 52,924 USD | |
2024-04-02 | 2024-04-01 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
1,518
-0.1%
7.3111,097 USD |
1,518 -0.1% | 7.31 | 11,097 USD | |
2024-02-22 | 2024-02-20 |
Ardelyx Inc
(ARDX)
|
S Sale |
22,917
-1.7%
8.75200,439 USD |
22,917 -1.7% | 8.75 | 200,439 USD | |
2023-05-25 | 2023-05-23 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
11,357
-1.3%
3.6541,489 USD |
11,357 -1.3% | 3.65 | 41,489 USD | |
2023-03-21 | 2023-03-17 |
Amicus Therapeutics Inc
(FOLD)
|
S Sale |
4,408
-6.8%
11.3349,943 USD |
4,408 -6.8% | 11.33 | 49,943 USD | |
2023-02-24 | 2023-02-21 |
Ardelyx Inc
(ARDX)
|
S Sale |
13,449
-1.5%
3.0040,360 USD |
13,449 -1.5% | 3.00 | 40,360 USD | |
2022-11-23 | 2022-11-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
5,936
-0.9%
1.9511,571 USD |
5,936 -0.9% | 1.95 | 11,571 USD | |
2022-11-23 | 2022-11-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
121
-0.0%
1.94235 USD |
121 -0.0% | 1.94 | 235 USD | |
2022-11-23 | 2022-11-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
162
-0.0%
1.94314 USD |
162 -0.0% | 1.94 | 314 USD | |
2022-09-01 | 2022-08-31 |
Ardelyx Inc
(ARDX)
|
PP Planned purchase |
3,000
+0.5%
0.621,856 USD |
3,000 +0.5% | 0.62 | 1,856 USD | |
2022-08-24 | 2022-08-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
76
-0.0%
0.9874 USD |
76 -0.0% | 0.98 | 74 USD | |
2022-08-24 | 2022-08-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
54
-0.0%
0.9853 USD |
54 -0.0% | 0.98 | 53 USD | |
2022-08-24 | 2022-08-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
6,016
-0.9%
0.985,918 USD |
6,016 -0.9% | 0.98 | 5,918 USD | |
2022-06-08 | 2022-06-06 |
Ardelyx Inc
(ARDX)
|
S Sale |
2,144
-0.3%
0.641,363 USD |
2,144 -0.3% | 0.64 | 1,363 USD | |
2022-06-08 | 2022-06-06 |
Ardelyx Inc
(ARDX)
|
S Sale |
101,480
-13.1%
0.6566,053 USD |
101,480 -13.1% | 0.65 | 66,053 USD | |
2022-05-23 | 2022-05-20 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
6,124
-0.8%
0.674,112 USD |
6,124 -0.8% | 0.67 | 4,112 USD | |
2022-05-04 | 2022-05-02 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
15,000
-29.0%
6.99104,891 USD |
15,000 -29.0% | 6.99 | 104,891 USD | |
2022-02-25 | 2022-02-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
6,229
-0.8%
0.674,173 USD |
6,229 -0.8% | 0.67 | 4,173 USD | |
2021-11-24 | 2021-11-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
2,607
-0.4%
0.992,586 USD |
2,607 -0.4% | 0.99 | 2,586 USD | |
2021-05-21 | 2021-05-20 |
Ardelyx Inc
(ARDX)
|
S Sale |
2,534
-1.2%
7.0917,960 USD |
2,534 -1.2% | 7.09 | 17,960 USD | |
2021-02-24 | 2021-02-22 |
Ardelyx Inc
(ARDX)
|
S Sale |
2,534
-1.2%
6.8817,440 USD |
2,534 -1.2% | 6.88 | 17,440 USD | |
2020-09-17 | 2020-09-15 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
106,337
-50.4%
5.61596,285 USD |
106,337 -50.4% | 5.61 | 596,285 USD | |
2020-07-06 | 2020-07-02 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
23,128
-48.7%
7.01162,130 USD |
23,128 -48.7% | 7.01 | 162,130 USD | |
2020-06-03 | 2020-06-01 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
5,000
-24.8%
12.6563,261 USD |
5,000 -24.8% | 12.65 | 63,261 USD | |
2020-06-02 | 2020-06-01 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
23,128
-33.3%
7.33169,635 USD |
23,128 -33.3% | 7.33 | 169,635 USD | |
2020-05-05 | 2020-05-05 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
4,486
-6.1%
7.0331,536 USD |
4,486 -6.1% | 7.03 | 31,536 USD | |
2020-05-05 | 2020-05-04 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
15,941
-17.7%
7.01111,686 USD |
15,941 -17.7% | 7.01 | 111,686 USD | |
2020-04-17 | 2020-04-17 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
9,428
-9.5%
7.0266,169 USD |
9,428 -9.5% | 7.02 | 66,169 USD | |
2020-04-17 | 2020-04-16 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
10,500
-9.6%
7.0173,642 USD |
10,500 -9.6% | 7.01 | 73,642 USD | |
2020-04-17 | 2020-04-15 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
500
-0.5%
7.033,515 USD |
500 -0.5% | 7.03 | 3,515 USD | |
2020-03-04 | 2020-03-02 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
20,428
-15.6%
7.01143,284 USD |
20,428 -15.6% | 7.01 | 143,284 USD | |
2020-03-04 | 2020-03-02 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
11,123
-5.1%
7.0077,861 USD |
11,123 -5.1% | 7.00 | 77,861 USD | |
2020-02-07 | 2020-02-05 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
25,000
-10.8%
7.32182,928 USD |
25,000 -10.8% | 7.32 | 182,928 USD | |
2019-06-06 | 2019-06-04 |
Ardelyx Inc
(ARDX)
|
PS Planned sale |
10,054
-3.8%
2.5425,551 USD |
10,054 -3.8% | 2.54 | 25,551 USD | |
2019-06-04 | 2019-06-03 |
Amicus Therapeutics Inc
(FOLD)
|
PS Planned sale |
5,000
-36.0%
11.1655,776 USD |
5,000 -36.0% | 11.16 | 55,776 USD | |
2019-01-04 | 2019-01-02 |
Ardelyx Inc
(ARDX)
|
S Sale |
19,644
-7.0%
1.7033,418 USD |
19,644 -7.0% | 1.70 | 33,418 USD |